Upbeat Test Results For BioSante By: MarketMinute.com Stock News August 13, 2009 at 14:57 PM EDT Shares of BioSante Pharmaceuticals Inc. (Nasdaq: BPAX) surged 29 cents to $2.07 after the company reported positive late stage results for its testosterone gel for women.